HYDROYSIS OF VITAMIN A ESTERS IN LIVER

Information

  • Research Project
  • 6940591
  • ApplicationId
    6940591
  • Core Project Number
    R01DK044498
  • Full Project Number
    5R01DK044498-12
  • Serial Number
    44498
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1992 - 31 years ago
  • Project End Date
    8/15/2006 - 17 years ago
  • Program Officer Name
    MAY, MICHAEL K.
  • Budget Start Date
    7/1/2005 - 18 years ago
  • Budget End Date
    8/15/2006 - 17 years ago
  • Fiscal Year
    2005
  • Support Year
    12
  • Suffix
  • Award Notice Date
    6/27/2005 - 18 years ago

HYDROYSIS OF VITAMIN A ESTERS IN LIVER

DESCRIPTION (provided by applicant): Hydrolysis of retinyl esters (RE) in the liver plays a key role in the body's metabolism of vitamin A. Dietary vitamin A enters the liver as RE in chylomicron remnants, which undergo hydrolysis and reesterification for storage. Prior to mobilization, RE are hydrolyzed and free retinol binds to retinol-binding protein for secretion into the plasma. Neutral and acid retinyl ester hydrolases (REHs) have been purified from rat liver and shown by sequence analysis to be carboxylesterases, ES-2 and ES-10. The goal of this project is to define the role of ES-2, ES-10, and the related ES-3 and ES-4, in the metabolism of vitamin A. Carboxylesterases have been studied with other substrates, but it is not known if they are important in vitamin A metabolism. Their efficiencies in catalyzing the hydrolysis of RE compared with other esters are also unknown. These gaps in knowledge will be explored with the following specific aims: AIM 1: Enzymoloqy of REHs. Enzyme kinetics will be used to study the substrate specificity of the carboxylesterases and to test the hypothesis that these enzymes differ in their intrinsic ability to catalyze the hydrolysis of RE and other lipid esters. AIM 2: Tissue distribution of carboxylesterases. Real-time PCR (for mRNA), immunodetection (for protein) and enzyme assay will be used to define the levels and distributions of enzymes in various tissues and to test the hypothesis that the carboxylesterases are present in peripheral tissues as well as in liver. AIM 3: Cell type distribution in liver. Laser Capture Microdissection and cell separations coupled with real-time PCR, immunodetection, and enzyme assays will be used to define the distribution of carboxylesterases between stellate cells & hepatocytes and to test the hypotheses that carboxylesterase ES-2 is localized exclusively in hepatocytes and that carboxylesterase ES-10 is localized in hepatocytes and stellate cells. AIM 4: Physiologic roles of the carboxylesterases in the metabolism of RE in cultured cells, cDNA transfection and RNA interference will be used to modulate carboxylesterase enzyme levels to test the hypothesis that the various carboxylesterases play a metabolic role in the hepatic uptake and/or metabolism of chylomicron RE, and to test the hypothesis that the carboxylesterases play a metabolic role in the turnover of intracellular RE and cholesteryl esters in cells that store them.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R01
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    235875
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    848
  • Ed Inst. Type
  • Funding ICs
    NIDDK:235875\
  • Funding Mechanism
  • Study Section
    NTN
  • Study Section Name
    Nutrition Study Section
  • Organization Name
    U.S. DEPARTMENT OF AGRICULTURE
  • Organization Department
  • Organization DUNS
  • Organization City
    WASHINGTON
  • Organization State
    DC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20250
  • Organization District
    UNITED STATES